Anti-hyperalgesic and anti-allodynic effects of intrathecal nociceptin/orphanin FQ in rats after spinal cord injury, peripheral nerve injury and inflammation

Pain

Volumn 76, Issue 3, 1998, Pages 385-393

  Hao, Jing Xia ^a   Xu, Isabella S ^a   Wiesenfeld Hallin, Zsuzsanna ^a   Xu, Xiao Jun ^a  

^a Div Clin Neurophysiol   (Sweden)

Author keywords

Inflammation; Neuropathic pain; Nociceptin; Opioids; Orphanin FQ; Spinal cord

Indexed keywords

NALOXONE; NOCICEPTIN; OPIATE RECEPTOR;

ALLODYNIA; ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HYPERALGESIA; INFLAMMATION; INTRATHECAL DRUG ADMINISTRATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SPINAL CORD INJURY;

EID: 0032104547     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(98)00071-2     Document Type: Article

References (58)

1. Besse D., Weil-Fugazza J., Lombard M.-C., Butler S.H., Besson J.-M. Monoarthritis induces complex changes in μ-, δ- and κ-opioid binding sites in the superficial dorsal horn of the rat spinal cord. Eur. J. Pharmacol. 22:1992;123-131.
2. Bian D., Nichols M.L., Ossipov M.H., Lai J., Porreca F. Characterization of the antiallodynic efficacy of morphine in a model of neuropathic pain in rats. NeuroReport. 6:1995;1981-1984.
3. Bunzow J.R., Saez C., Mortrud M., Bouvier C., Williams J.T., Low M., Grandy D.K. Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ receptor type. FEBS Lett. 347:1994;284-288.
4. Cesselin F. Opioid and anti-opioid peptides. Fundam. Clin. Pharmacol. 9:1995;409-433.
5. Connor M., Vaughan C.W., Chieng B., Christie M.J. Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br. J. Pharmacol. 119:1996;1614-1618.
6. Craig A.D., Bushnell M.C. The thermal grill illusion: unmasking the burn of cold pain. Science. 265:1994;252-255.
7. Craig A.D., Hunsley S.J. Morphine enhances the activity of thermoreceptive cold-specific lamina I spinothalamic neurons in the cat. Brain Res. 558:1991;93-97.
8. Dickenson A.H. Neurophysiology of opioid poorly responsive pain. Cancer Surveys. 21:1994;5-16.
9. Draisci G., Kajander K.C., Dubner R., Bennett G.J., Iadarola M.J. Up-regulation of opioid gene expression in spinal cord evoked by experimental nerve injuries and inflammation. Brain Res. 560:1991;186-192.
10. Dubner R., Ruda M.A. Activity-dependent neuronal plasticity following tissue injury and inflammation. Trends Neurosci. 15:1992;96-103.
11. Erb K., Liebel J.T., Tegeder I., Zeilhofer H.U., Brune K., Geisslinger G. Spinally delivered nociceptin/orphanin FQ reduces flinching behaviour in the rat formalin test. NeuroReport. 8:1997;1967-1970.
12. Faber E.S.L., Chambers J.P., Evans R.H., Henderson G. Depression of glutamatergic transmission by nociceptin in the neonatal rat hemisected spinal cord preparation in vitro. Br. J. Pharmacol. 119:1996;189-190.
13. Gogas K.R., Thompson J., Hunter J.C. Effects of centrally administered orphanin FQ on tail flick latency and motor activity in rats. Soc. Neurosci. Abstr. 22:1996;1368.
14. Gray W.D., Osterberg A.C., Scuto T.J. Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method. J. Pharmacol. Exp. Ther. 72:1970;154-162.
15. Grisel J.E., Moril J.S., Belknap J.K., Grandy D.K. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide. NeuroReport. 7:1996;2125-2129.
16. Hao J.-X., Wiesenfeld-Hallin Z., Xu X.-J. Lack of cross-tolerance between the antinociceptive effect of intrathecal orphanin FQ and morphine in the rat. Neurosci. Lett. 223:1997;49-52.
17. Hao J.-X., Yu W., Xu X.-J., Wiesenfeld-Hallin Z. Capsaicin-sensitive afferents mediate chronic cold, but not mechanical, allodynia-like behavior in spinally injured rats. Brain Res. 196:1996;116-118.
18. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
19. Henderson G., McKnight A.T. The orphan opioid receptor and its endogenous ligand-nociceptin/orphanin FQ. Trends Pharmacol. Sci. 18:1997;293-300.
20. Hylden J.L., Thomas D.A., Iadarola M.J., Nahin R.L., Dubner R. Spinal opioid analgesic effects are enhanced in a model of unilateral inflammation/hyperalgesia: possible involvement of noradrenergic mechanisms. Eur. J. Pharmacol. 194:1991;135-143.
21. King M.A., Rossi G.C., Chang A.H., Williams L., Pasternak G.W. Spinal analgesic activity of orphanin FQ/nociceptin and its fragments. Neurosci. Lett. 223:1997;113-116.
22. Kupers, R., Yu, W., Persson, J.K.E., Xu, X.-J. and Wiesenfeld-Hallin, Z., Photochemically-induced ischemia of the rat sciatic nerve produces a dose-dependent and highly reproducible mechanical, heat and cold allodynia, and signs of spontaneous pain, Pain, (1998) in press.
23. Lee Y.-W., Chaplan S.R., Yaksh T.L. Systemic and supraspinal, but not spinal, opiates suppress allodynia in a rat neuropathic pain model. Neurosci. Lett. 186:1995;111-114.
24. Liebel J.T., Swandulla D., Zeilhofer H.U. Modulation of excitatory synaptic transmission by orphanin FQ in superficial dorsal horn neurones of the neonatal rat spinal cord. Br. J. Pharmacol. 121:1997;425-432.
25. Maekawa K., Minami M., Masuda T., Satoh M. Expression of μ- and κ-, but not δ-, opioid receptor mRNAs is enhanced in the spinal dorsal horn of the arthritic rats. Pain. 64:1996;365-371.
26. Mao, J., Price, D.D., and Mayer, D.J., Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain, Pain, 61 (1995a) 353-64.
27. Mao, J., Price, D.D. and Mayer, D.J., Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions, Pain, 62 (1995b) 259-74.
28. Meng F., Taylor L.P., Hoversten M.T., Ueda Y., Ardati A., Reinscheid R.K., Monsman F.J., Watson S.J., Civelli O., Akil H. Moving from the orphanin FQ receptor to an opioid receptor using four point mutations. J. Biol. Chem. 13:1996;32016-32020.
29. Meunier J.-C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J.-L., Guillemot J.-C., Ferrara P., Monsarrat B., Mazarguil H., Vassart G., Parmentier M., Costentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 377:1995;532-535.
30. Millan M.J., Millan M.H., Czlonkowski A., Höllt V., Pilcher C.W.T., Herz A., Colpaert F.C. A model of chronic pain in the rat: responses of multiple opioid systems to adjuvant-induced arthritis. J. Neurosci. 6:1986;899-906.
31. Mogil J.S., Grisel J.E., Reinscheid R.K., Civelli O., Belknap J.K., Grandy D.K. Orphanin FQ is a functional anti-opioid peptide. Neuroscience. 75:1996;333-337.
32. O'Callaghan J.T., Holtzman S.G. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure. J. Pharmacol. Exp. Ther. 192:1975;497-505.
33. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. Inhibition by spinal morphine of the tail-flick response is attenuated in rats with nerve ligation injury. Neurosci. Lett. 199:1995;83-86.
34. Reinscheid R.K., Nothacker H.-P., Bourson A., Ardati A., Henningsen R.A., Bunzow J.R., Grandy D.K., Langen H., Monsma F.J., Civelli O. Orphanin FQ: a neuropeptide that activates an opioid-like G protein-coupled receptor. Science. 270:1995;792-794.
35. Riedl M., Shuster S., Vulchanova L., Wang J., Loh H.H., Elde R.P. Orphanin FQ/nociceptin-immunoreactive nerve fibers parallel those containing endogenous opioids in rat spinal cord. NeuroReport. 7:1996;1369-1372.
36. Rossi G.C., Leventhal L., Pasternak G.W. Naloxone sensitive nociceptin-induced analgesia in mice. Eur. J. Pharmacol. 311:1996;R7-R8.
37. Saeki S., Yaksh T.L. Suppression of nociceptive responses by spinal mu opioid agonists: effects of stimulus intensity and agonist efficacy. Anesth. Analg. 77:1993;263-274.
38. Schuligoi, R., Amann, R., Angelberger, P. and Peskar, B.A., Determination of nociceptin-like immunoreactivity in the rat dorsal spinal cord, 224 (1997) 136-138.
39. Schulz S., Schreff M., Nüb D., Gramsch C., Höllt V. Nociceptin/orphanin FQ and opioid peptides show overlapping distribtuion in pain-modulatory brain regions. NeuroReport. 7:1996;3021-3025.
40. Stanfa L.C., Chapman V., Kerr N., Dickenson A.H. Inhibitory action of nociceptin on spinal dorsal horn neurones of the rat in vivo. Br. J. Pharmacol. 118:1996;1875-1877.
41. Stanfa L.C., Dickenson A.H. Cholecystokinin as a factor in the enhanced potency of spinal morphine following carrageenin inflammation. Br. J. Pharmacol. 108:1993;967-973.
42. Stanfa L., Dickenson A. Spinal opioid systems in inflammation. Inflammation Res. 44:1995;231-241.
43. Stanfa L.C., Dickenson A.H., Xu X.-J., Wiesenfeld-Hallin Z. Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol. Sci. 15:1994;65-66.
44. Storkson R.V., Kjorsvik A., Tjolsen A., Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J. Neurosci. Methods. 65:1996;167-172.
45. Tian, J.-H., Xu, W., Fang, Y., Mogil, J.S., Grisel, J.E., Grandy, D.K. and Han, J.-S., Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat, Br. J. Pharmacol., 120 (1997a) 676-680.
46. Tian, J.-H., Xu, W., Zhang, W., Fang, Y., Grisel, J.E., Mogil, J.S., Grandy, D.K. and Han, J.-S., Involvement of endogenous orphanin FQ in electroacupuncture-induced analgesia, NeuroReport, 8 (1997b) 497-500.
47. Vaughan C.W., Christie M.J. Increase by the ORL(1) receptor (opioid receptor-like (1)) ligand, orphanin FQ, on inwardly rectifying K conductance in dorsal raphe nucleus neurones. Br. J. Pharmacol. 117:1996;1609-1611.
48. Wang X.-M., Zhang K.M., Mokha S.S. Nociceptin (orphanin FQ), an endogenous ligand for the ORL1 (opioid-receptor-like 1) receptor, modulates responses of trigeminal neurons evoked by excitatory amino acids and somatosensory stimuli. J. Neurophysiol. 76:1996;3568-3572.
49. Wick M.J., Minnerath S.R., Lin X., Elde R.P., Law P.-Y., Loh H.H. Isolation of a novel cDNA encoding a putative membrane receptor with high homology to the cloned μ, δ, and κ opioid receptors. Brain Res. 27:1994;37-44.
50. Wiesenfeld-Hallin Z., Xu X.-J. The role of cholecystokinin in nociception, neuropathic pain and opiate tolerance. Regul. Pept. 65:1996;23-28.
51. Xu X.-J., Hao J.-X., Aldskogius H., Seiger Å., Wiesenfeld-Hallin Z. Chronic pain-related syndrome in rats after ischemic spinal cord lesion: a possible animal model for pain in patients with spinal cord injury. Pain. 48:1992;279-290.
52. Xu X.-J., Wiesenfeld-Hallin Z. The threshold for the depressive effect of intrathecal morphine on the spinal nociceptive flexor reflex is increased during autotomy after sciatic nerve section in rats. Pain. 46:1991;223-229.
53. Xu X.-J., Hao J.-X., Wiesenfeld-Hallin Z. Nociceptin or antinociceptin: potent spinal antinociceptive effect of orphanin FQ/nociceptin in the rat. NeuroReport. 7:1996;2092-2094.
54. Yaksh T.L. Spinal opiates: a review of their effect on spinal function with emphasis on pain processing. Acta Anaesthesiol. Scand. Suppl. 85:1987;25-37.
55. Yaksh, T.L., The spinal pharmacology of anomalous pain processing. In: K.L. Casey (Ed.), Pain and Central Nervous System Disease: the Central Pain Syndromes. Raven Press, New York, 1991, pp. 243-256.
56. Yamamoto, T., Nozaki-Taguchi, N. and Kimura, S., Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by carageenan injection into the rat paw, Brain Res., 754 (1997a) 329-332.
57. Yamamoto, T., Nozaki-Taguchi, N. and Kimura, S., Effects of intrathecally administered nociceptin, an opioid receptor-like1 (ORL1) receptor agonist, on the thermal hyperalgesia induced by unilateral constriction injury to the sciatic nerve in the rat, Neurosci. Lett., 224 (1997b) 107-110.
58. Yu, W., Hao, J.-X., Xu, X.-J. and Wiesenfeld-Hallin, Z., Comparison of the anti-allodynic and antinociceptive effects of systemic, intrathecal and intracerebroventricular morphine in a rat model of central neuropathic pain, Eur. J. Pain, 1 (1997) 17-29.